| Response-guided and -unguided treatment of chronic hepatitis C. | |
| | |
MedLine Citation:
|
PMID: 22212575 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Over time, HCV therapy with pegylated interferon and ribavirin has evolved from a fixed duration strategy to one of response guided therapy and this has enabled us to optimize treatment duration. With the evolution of protease inhibitor based therapy, the paradigm of response guided therapy has further helped in decreasing treatment duration in greater number of patients and which then translates into shorter duration of adverse events. However, several population groups have done better with extended duration therapy as opposed to response guided therapy despite early viral clearance. These include the Black population, and those with cirrhosis, decreased interferon sensitivity, and unfavorable IL28B genotypes. The proper identification of those who might benefit from extended duration HCV therapy will undoubtedly lead to optimal care and outcomes. |
| | |
Authors:
|
K Rajender Reddy; Frederick Lin; Fabien Zoulim |
Related Documents
:
|
21861015 - Use of assisted reproductive technology to separate sperm from human immunodeficiency v... 21934555 - Cost-effectiveness of using haart in prevention of mother-to-child transmission in the ... 21767835 - Risk factors for very preterm delivery and delivery of very-small-for-gestational-age i... 21749785 - Association of patients' geographic origins with viral hepatitis co-infection patterns,... 22701555 - Adherence as a predictor of sexual behaviors in people living with hiv/aids during the ... 20978395 - Biomarkers of fibrosis and impaired liver function in chronic hepatitis c: how well do ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Liver international : official journal of the International Association for the Study of the Liver Volume: 32 Suppl 1 ISSN: 1478-3231 ISO Abbreviation: Liver Int. Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-01-03 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101160857 Medline TA: Liver Int Country: England |
Other Details:
|
Languages: eng Pagination: 64-73 Citation Subset: IM |
Copyright Information:
|
© 2012 John Wiley & Sons A/S. |
Affiliation:
|
Department of Medicine, Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Triple combination treatment for chronic hepatitis C with Protease Inhibitors, pegylated interferon ...
Next Document: IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepati...